4-R-4H-DITHIENO[3,2-B:2',3'-D]PYRROLE, 95.0%, 250mg

(+)-N,N,N',N'-Tetramethyl-L-tartardiamide>98.0%(GC)5g

4-(2-Methyl-2H-tetrazol-5-yl)-benzenesulfonamide, 95.0%, 1g

(2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol, 97.0%, 250mg

Flacon à col étroit 310, 2500 ml, 45 mm, 3 pièce(s)

2H-benzo[b][1,4]thiazin-3(4H)-one 1,1-dioxide, 90%, 250mg

2-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde, 95.0%, 5g

5-Aminoisoxazole-4-carbonitrile, 95.0%, 5g

5-Bromo-2,4-dimethoxypyrimidine, 97.0%, 1g

4-BENZOFURANCARBOXALDEHYDE, 5-FLUORO-, 95.0%, 5g

Ethyl 4-chloropyrimidine-5-carboxylate, 95.0%, 1g

3-Bromofluoranthene, 97.0%, 25g

2-AZASPIRO[3.5]NONANE-2-CARBOXYLIC ACID, 7-HYDROXY-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 100mg